Are We Using GLP-1 Medications All Wrong? with Dr. Ben Bikman
What if We're Using GLP-1 Medications All Wrong?
Drugs like Ozempic, Wegovy, and Mounjaro are transforming the landscape of medical weight loss, but could their side effects be a sign that we’re not harnessing their full therapeutic potential?
In this eye-opening conversation, Dr. Ben Bikman, metabolic health researcher and professor at BYU, joins Dr. Bret Scher to explore a powerful new framework: using GLP-1 medications at low doses and for short durations to help curb carbohydrate cravings, break addictive eating cycles, and support long-term metabolic health.
Rather than prescribing high…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.